Clincosm LogoSign in Get a demo

Malignant Solid Tumor

Showing 1 - 25 of 38
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Solid Tumor Trial (GEN1042, Pembrolizumab, Cisplatin)

Not yet recruiting
  • Malignant Solid Tumor
  • GEN1042
  • +4 more
  • (no location specified)
Sep 21, 2023

Malignant Solid Tumor Trial in Hackensack, New York, Spokane (ZL-1218, Pembrolizumab)

Recruiting
  • Malignant Solid Tumor
  • Hackensack, New Jersey
  • +2 more
May 4, 2023

Cutaneous Tumor, Malignant Solid Tumor Trial (JCXH-211 Injection)

Not yet recruiting
  • Cutaneous Tumor
  • Malignant Solid Tumor
  • JCXH-211 Injection
  • (no location specified)
Feb 13, 2023

Tumor, Tumor, Solid, Metastasis Trial in United States (nab-sirolimus)

Recruiting
  • Tumor
  • +20 more
  • Mobile, Alabama
  • +81 more
Jan 24, 2023

Advanced Solid Tumor, Malignant Solid Tumor Trial in Japan, United States (DS-7300a)

Recruiting
  • Advanced Solid Tumor
  • Malignant Solid Tumor
  • Los Angeles, California
  • +21 more
Jan 5, 2023

Malignant Solid Tumor, Non Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Trial in Worldwide (GEN1042, Pembrolizumab,

Recruiting
  • Malignant Solid Tumor
  • +5 more
  • GEN1042
  • +8 more
  • San Diego, California
  • +27 more
Dec 24, 2022

Malignant Solid Tumor, Oncology Trial in Groningen (GEH200520 Injection / GEH200521 (18F) Injection - Part A, Dynamic and Static

Not yet recruiting
  • Malignant Solid Tumor
  • Oncology
  • GEH200520 Injection / GEH200521 (18F) Injection - Part A
  • +3 more
  • Groningen, Netherlands
    UMC Groningen
Nov 17, 2022

Malignant Solid Tumor, Metastatic EphA2 Positive Cancer Trial in Heidelberg (DS-8895a 1 mg/kg, DS-8895a 3 mg/kg, DS-8895a 10

Completed
Has Results
  • Malignant Solid Tumor
  • Metastatic EphA2 Positive Cancer
  • DS-8895a 1 mg/kg
  • +2 more
  • Heidelberg, Victoria, Australia
    Austin Health
Oct 3, 2022

Cutaneous Tumor, Malignant Solid Tumor Trial in Houston (JCXH-211)

Not yet recruiting
  • Cutaneous Tumor
  • Malignant Solid Tumor
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Sep 9, 2022

Refractory Solid Tumor, Hepatocellular Carcinoma, Malignant Solid Tumor Trial in Memphis (Atezolizumab, Sorafenib, Bevacizumab)

Recruiting
  • Refractory Solid Tumor
  • +4 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 4, 2022

Malignant Solid Tumor Trial in Nashville (Ifetroban Sodium, Placebo)

Recruiting
  • Malignant Solid Tumor
  • Ifetroban Sodium
  • Placebo
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Jun 23, 2022

Malignant Solid Tumor Trial in Worldwide (BMS-986179, Nivolumab, rHuPH20)

Completed
  • Malignant Solid Tumor
  • BMS-986179
  • +2 more
  • Chicago, Illinois
  • +23 more
May 25, 2022

Malignant Solid Tumor, Metastatic Cancer, Advanced Cancer Trial in Sacramento, New Brunswick (RRx-001, Irinotecan)

Terminated
  • Malignant Solid Tumor
  • +2 more
  • Sacramento, California
  • +1 more
May 12, 2022

Malignant Solid Tumor Trial in Shanghai (Infusion of iNKT cells)

Completed
  • Malignant Solid Tumor
  • Infusion of iNKT cells
  • Shanghai, China
    Shanghai Public Health Clinical Center, Fudan University
May 6, 2022

Malignant Solid Tumor Trial in United States (ramucirumab (IMC-1121B), paclitaxel)

Completed
Has Results
  • Malignant Solid Tumor
  • Ann Arbor, Michigan
  • +5 more
Feb 14, 2022

Epithelial Tumors, Malignant, Malignant Solid Tumor Trial in Barcelona (NEXTGEN-TIL, Non-myeloablative Lymphodepletion (NMA-LD)

Recruiting
  • Epithelial Tumors, Malignant
  • Malignant Solid Tumor
  • NEXTGEN-TIL
  • +2 more
  • Barcelona, Spain
    Vall d'Hebron Institute of Oncology
Nov 25, 2021

Malignant Solid Tumor, Pain Trial in San Francisco (Acupuncture, Pain Counseling)

Completed
  • Malignant Solid Tumor
  • Pain
  • Acupuncture
  • Pain Counseling
  • San Francisco, California
  • +1 more
Oct 21, 2021

Malignant Solid Tumor Trial in Shanghai (Super circulating tumor infiltrating lymphocytes(ScTIL))

Recruiting
  • Malignant Solid Tumor
  • Super circulating tumor infiltrating lymphocytes(ScTIL)
  • Shanghai, Shanghai, China
  • +1 more
Jul 14, 2021

Malignant Solid Tumor Trial in Belgium, United States (NKTR-102 145 mg/m2, NKTR-102 120 mg/m2, NKTR-102 95 mg/m2)

Completed
Has Results
  • Malignant Solid Tumor
  • NKTR-102 145 mg/m2
  • +3 more
  • Los Angeles, California
  • +6 more
Jul 9, 2021

NSCLC, Malignant Solid Tumor Trial in United States (enzastaurin, erlotinib)

Completed
Has Results
  • Non-Small Cell Lung Cancer
  • Malignant Solid Tumor
  • Los Angeles, California
  • +9 more
Apr 20, 2021

Malignant Solid Tumor Trial in Belgium, Spain (AMC303)

Completed
  • Malignant Solid Tumor
  • Brussels, Belgium
  • +6 more
May 7, 2021

Malignant Solid Tumor Trial in Beijing, Linyi (ASKB589 Injection)

Active, not recruiting
  • Malignant Solid Tumor
  • ASKB589 Injection
  • Beijing, Beijing, China
  • +1 more
Feb 25, 2021

Malignant Solid Tumor Trial in Grand Rapids, Houston, Toronto (AVID200)

Unknown status
  • Malignant Solid Tumor
  • Grand Rapids, Michigan
  • +2 more
Dec 17, 2020

Malignant Solid Tumor Trial in Kanto Region (ONO-4538)

Completed
Has Results
  • Malignant Solid Tumor
  • ONO-4538
  • Kanto Region, Kanto, Japan
    (unnamed)
Sep 15, 2020

Malignant Solid Tumor Trial in Leuven, Liège, Wilrijk (Olaparib Treatment A, Olaparib Treatment B, Olaparib Treatment C)

Completed
  • Malignant Solid Tumor
  • Olaparib Treatment A
  • +3 more
  • Leuven, Belgium
  • +2 more
Sep 30, 2020